Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APDM Pharmaceuticals is an India-based pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of complex generic medications. Established in 2022 and headquartered in Ahmedabad, the company operates state-of-the-art manufacturing facilities capable of producing billions of units annually across various dosage forms, including solid orals, injectables, and ophthalmic solutions. APDM provides comprehensive services ranging from formulation R&D and analytical method development to commercial-scale manufacturing and global regulatory support. The company actively markets several generic products in the United States, including amlodipine/atorvastatin combinations and tramadol, and focuses on leveraging IoT-enabled manufacturing to ensure high quality and efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APDM Pharms.